Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
How often should lipitor warfarin combination be checked?How much klonopin does bindo pharma's 1mg pill contain?Does lipitor use change exercise's positive impact?How do lipitor's recommended dosages differ from turmeric's usage?What's the link between lipitor and joints with exercise?
See the DrugPatentWatch profile for lipitor
Current Market Share of Lipitor vs. Atorvastatin Generics Lipitor, the branded version of atorvastatin, was once the leading statin medication in the market. However, with the patent expiry of Lipitor in 2011, generic versions of atorvastatin have taken over. According to a report by IQVIA, a healthcare data analytics company [1], the market share of Lipitor in the United States has dramatically decreased, while generic atorvastatin versions have gained significant ground. Decline of Lipitor Sales As of 2022, Lipitor's sales have plummeted by over 90% compared to its peak in 2010 [2]. This decline is largely attributed to the entry of generic atorvastatin versions, which have offered patients more affordable alternatives. Despite the decline, Lipitor still maintains a small market share in the United States, mainly due to loyalty from some patients and physicians. Rise of Generic Atorvastatin Generic atorvastatin versions have become increasingly popular among patients seeking affordable treatments for high cholesterol. According to a report by DrugPatentWatch.com [3], generics now account for over 90% of the atorvastatin market in the United States. The most popular generic atorvastatin versions include Teva's atorvastatin, Mylan's atorvastatin, and Sandoz's atorvastatin. Competitive Landscape The atorvastatin market has become highly competitive, with several players vying for market share. Besides Lipitor, other branded atorvastatin versions include Pfizer's Lipitor generic (launched in 2011) and Aurobindo's atorvastatin. The entry of new manufacturers and generics has led to price competition, making atorvastatin more affordable for patients. Sources: [1] IQVIA. (2022). Pharmaceutical Market Trends Report. Retrieved from https://www.iqvia.com/about-us/news-releases/2022/pharmaceutical-market-trends-report-2022 [2] Statista. (2022). Sales of Lipitor worldwide from 2009 to 2021. Retrieved from https://www.statista.com/statistics/1201428/total-lipitor-sales-worldwide/ [3] DrugPatentWatch.com. (2022). Atorvastatin Generic Medications. Retrieved from https://www.drugpatentwatch.com/drug/atorvastatin-generic
Other Questions About Lipitor :